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Editorial
See corresponding article on page 950.
Twentieth-century trends in essential fatty acid intakes and the
predicted omega-3 index: evidence versus estimates1–3
William S Harris and David M Klurfeld
Although the health benefits of omega-3 (n–3) fatty acids are
widely appreciated, those of the omega-6 (n–6) fatty acids have
become somewhat controversial in recent years, with some view-
ing them as harmful at current intakes (1, 2) and others (3)
[including the American Heart Association (4)] supporting the
status quo. Understanding the relations between intakes of these
essential fatty acids and disease prevalence over time could in-
form the debate. To that end, this issue of the Journal contains
a report by Blasbalg et al (5) that attempts to reconstruct those
intakes and, from this information, to estimate fatty acid tissue
content (eg, the Omega-3 Index [red blood cell eicosapentaenoic
plus docosahexaenoic acid (EPA1DHA) (6)]). Low concentra-
tions of the latter have been linked to increased risk of total
mortality (7), cellular aging (8), depression (9), and acute cor-
onary syndromes (10).
In reconstructing historical intakes, Blasbalg et al (5) used US
Department of Agriculture (USDA) commodity disappearance
data and made multiple assumptions and estimations regarding,
for example, the completeness of USDA food and nutrient da-
tabases, the extent of wastage, the considerable differences in
the amount and types of foods shipped in from outside of the
United States (which would be particularly true for seafood), the
proportions consumed by people (as opposed to animals or used
for industrial purposes), and so forth. The USDA/Center for
Nutrition Policy and Promotion approach used by these authors
assumes that the fatty acid content of various foods did not
change over the second half of the 20th century. In fact, many
meat products, fats and oils (which were subjected to varying
degrees of hydrogenation), and processed foods containing ever-
changing blends of commodity oils entered the food supply
during this time. Consequently, Blasbalg et al’s reported intakes
of both short-chain [a-linolenic acid (ALA) and linoleic acid
(LA)] and long-chain, highly unsaturated fatty acids (HUFAs)
of the n26 and n23 series cannot easily be independently ver-
ified and must remain as rough estimates only.
One way to gauge the accuracy of their estimates, however, is
to compare them with published data from others obtained by
different approaches. For example, Taylor et al (11) reported
fatty acid intake data from the late 1980s in 234,426 individ-
uals in the Nurses’ Health Studies (NHS) and in the Health
Professionals Follow-Up Study. In addition, Sun et al (12)
reported dietary fatty acid composition in a small (n ¼ 306)
subset of women in the NHS. Both studies used the Willett food-
frequency questionnaire (FFQ) to estimate fatty acid intakes.
They (like Blasbalg et al) based their analysis primarily on the
USDA nutrient databases, which are not always complete or up-
to-date but are the gold standard for diet surveys. (These data-
bases use direct analysis for some foods, assume literature
values for others, impute values for still others, and formulate
generic recipes for many processed foods.) Importantly, Sun
et al also measured the fatty acid composition of red blood cells
from which the Omega-3 Index could be determined. The Sun
et al study thus affords an opportunity to evaluate 2 of the 1989
estimations made by Blasbalg et al: fatty acid intakes and the
Omega-3 Index [calculated by Blasbalg et al by using the Lands
equation (1)].
The relations between Blasbalg et al’s estimated intakes and
reported intakes in both Sun et al (12) and Taylor et al (11)
are shown in Table 1. For AA, ALA, and the LA:AA ratios,
there was relatively good agreement. However, LA intake was
overestimated in the former by ’45%, and intakes of EPA and
TABLE 1
Comparison of 1989 fatty acid intakes measured in Sun et al (12) and
Taylor et al (11) by the Willett food-frequency questionnaire and those








Linoleic (% of energy) 7.5 5.21 4.5
a-Linolenic (% of energy) 0.63 0.52 NA
Linoleic:a-linolenic ratio 11:1 10:1 NA
Eicosapentaenoic (% of energy) 0.01 0.04
0.09
Docosahexaenoic (% of energy) 0.02 0.08
Arachidonic (% of energy) 0.055 0.07 NA
1 NA, not available.
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DHA were underestimated by 3–4-fold. When the intake esti-
mates of Blasbalg et al (5) for LA and EPA+DHA are compared
with the reported intakes by Taylor et al (11), the estimates were
markedly higher and lower, respectively, than those reported. Be-
cause all of these authors used the same USDA databases, differ-
ences in estimated intakes between them cannot be attributed to
the use of different databases.
There are also problems with the predicted Omega-3 Index
[Figure 8 in Blasbalg et al (5)] derived from presumed fatty acid
intakes. This calculation is made by entering fatty acid intakes
into the Lands equation (provided in spreadsheet form as
‘‘mgSIMPLE-1.xls’’ and downloaded from http://efaeducation.
nih.gov/sig/food.html). This equation returns a value for n26
HUFAs as a percentage of total HUFAs. The n23 HUFAs as
a percentage of total HUFAs are calculated simply as 1 – the n–6
value. Blasbalg et al describe the n23 HUFA metric as being
related to the Omega-3 Index in a ‘‘linear and robust’’ manner
via a regression equation published by Lands (13). The estimated
Omega-3 Index was ’3.5% in 1989 according to Blasbalg et al
(5). This was 28% lower than the 4.9% actually observed in Sun
et al (12).
To test how well fatty acid intakes translate into the Omega-3
Index, data from Sun et al (12) were entered (as a percentage
of energy) into mgSIMPLE-1. The predicted value (6.15%) was
40% higher than that observed (4.86%), which itself was ’39%
higher than that predicted by Blasbalg et al from food disap-
pearance data (’3.5%) (Figure 1). Therefore, Blasbalg et al did
not match the observed Omega-3 Index in this cohort because
both their assumed fatty acid intakes and the equation used to
estimate the Omega-3 Index are flawed.
We know the limitations of routinely used databases and diet
surveys; here, we have a different approach that may have the
potential to give us better information about foods consumed spo-
radically or of unknown fatty acid content, but the limits of this
data set for predicting fatty acid consumption are unclear. Al-
though this is an interesting exercise in collating food disappear-
ance data, the inescapable uncertainties inherent in both the data
and in the extrapolations to tissue compositions used by Blasbalg
et al infuse more confusion than information into the field. It
would be unfortunate indeed if these estimations were viewed
as facts and used in future publications to draw conclusions re-
garding diet and disease relations across the 20th century.
WSH is a consultant to several companies with interests in omega-3 fatty
acids including GlaxoSmithKline, Monsanto/Solae, Omthera, and Acasti. He
is also the President of OmegaQuant, LLC, which offers blood omega-3 test-
ing for researchers and clinicians. DMK had no potential conflicts to disclose.
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FIGURE 1. Data from the Nurses’ Health Study [collected in 1989 and
reported by Sun et al (12)] were used to test the estimations of Blasbalg et al
(5).:, the predicted Omega-3 Index from the Lands equation based on
known fatty acid intake in Sun et al (12); d, the reported Omega-3 Index
in Sun et al (12); n, the Blasbalg et al (5) predicted Omega-3 Index based on
their 1989 estimated fatty acid intakes. HUFA, highly unsaturated fatty acids.
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